Abstract:RASopathies are a group of genetic disorders caused by mutations in genes encoding components and regulators of the RAS/MAPK signaling pathway, resulting in overactivation of signaling. RASopathy patients exhibit distinctive facial features, cardiopathies, growth and skeletal abnormalities, and varying degrees of developmental delay, neurocognitive impairment, intellectual disabilities, and attention deficits. At present, it is unclear how RASopathy mutations cause neurocognitive impairment and what their neuron-specific cellular and network phenotypes are. Such knowledge would be crucial for the development of specific therapies, which are still lacking for the treatment of the neurocognitive and behavioral symptoms in RASopathies. Here, we investigated the effect of RASopathy mutations on the establishment and functional maturation of neuronal networks. We isolated cortical neurons from RASopathy mouse models and cultured them for several weeks in multiwell plates with implanted multielectrode arrays. The arrays were used for longitudinal recordings of spontaneous activity in developing networks as well as for recordings of evoked responses in mature neurons. To facilitate the analysis of large and complex data sets resulting from long-term multielectrode recordings, we developed MATLAB-based tools for data processing, analysis and statistical evaluation. Longitudinal analysis of spontaneous network activity revealed a convergent developmental phenotype in neurons carrying the gain-of-function RASopathy mutations and . The phenotype was more pronounced at early time points and faded out over time, suggesting compensatory effects during network maturation. Nevertheless, persistent differences in excitatory/inhibitory balance and network excitability were observed in mature networks. This study improves the understanding of the complex relationship between genetic mutations and clinical manifestations in RASopathies by adding insights into functional network processes as an additional piece of the puzzle.

Interactions between Ras and Rap signaling pathways during neurodevelopment in health and disease

[Research Advances in the Role of Mtor Signaling Pathway in Autism Spectrum Disorder].

Ras, RhoA, and vascular pharmacology in neurodevelopment and aging

Neurodevelopmental Aspects of RASopathies

Non-Mammalian Models for Understanding Neurological Defects in RASopathies

Developmental effect of RASopathy mutations on neuronal network activity on a chip

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Social Communication in Ras Pathway Disorders: A Comprehensive Review from Genetics to Behavior in Neurofibromatosis Type 1 and Noonan Syndrome

RASopathies influences on neuroanatomical variation in children.

RAS pathway: The new frontier of brain mosaicism in epilepsy

Dopaminergic Signaling is Linked to Neurodevelopmental Deficits in Autism Spectrum Disorder (ASD)

Pathophysiological Mechanisms in Neurodevelopmental Disorders Caused by Rac GTPases Dysregulation: What’s behind Neuro-RACopathies

Small GTPases of the Ras and Rho Families Switch on/off Signaling Pathways in Neurodegenerative Diseases

Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment

Rho GTPase Regulators and Effectors in Autism Spectrum Disorders: Animal Models and Insights for Therapeutics

Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling

The neurodevelopmental role of dopaminergic signaling in neurological disorders

The Progress of the Biological Function of Rap Signaling in Nervous System

RhoA Signaling in Neurodegenerative Diseases